Vitiligo research Current Status of Cell-Based Therapies for Vitiligo Abstract Vitiligo is a chronic pigmentary disease with complex etiology, the signs of which are…VIPOC23 February 2023
Vitiligo research Vitiligo in Children: A Review of Conventional Treatments Introduction Vitiligo is an acquired, chronic, maybe autoimmune, pigmentary disorder characterised by white macules and…VIPOC25 January 2023
Vitiligo research Assessing Behavioral and Psychological Symptoms in Chinese Vitiligo Patients Background: Vitiligo is a common, acquired depigmenting disorder. The pathogenesis is not clear, neuropsychological factors may…VIPOC20 January 2023
Vitiligo research Approaching Nonsegmental Vitiligo with a Focus on the Immune-Mediated Aspects of the Disease and a New Treatment Option to Consider Managing vitiligo has been a challenging journey. There have been limited options available for dermatologists…VIPOC4 January 2023
Vitiligo research The Genetic Basis of Vitiligo Vitiligo is a complex disease in which autoimmune destruction of epidermal melanocytes results inpatches of…VIPOC2 December 2022
Vitiligo research What to know about laser treatments for vitiligo Vitiligo can cause the skin to lose its natural color. Laser therapy can help repigment…VIPOC2 December 2022
Vitiligo research VITILIGO: A REVIEW OF SOME FACTS LESSER KNOWN ABOUT DEPIGMENTATION James J Nordlund Abstract Vitiligo is a disorder that causes the destruction of melanocytes. It…VIPOC10 November 2022
Vitiligo research Translational Research in Vitiligo Erica L. Katz and John E. Harris Vitiligo is a disease of the skin characterized…VIPOC28 October 2022
Vitiligo research FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura) The JAK inhibitor cream is the first medication that can restore pigment in people with this autoimmune disease. By Becky Upham July 22, 2022 On July 18, the U.S. Food and Drug Administration…VIPOC27 July 2022
VitiligoVitiligo researchvitiligo treatment Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross-sectional controlled study Part 2 Separated, n (%) 4 (12.9) 4(13.8) 0 Number of siblings 1, n (%) 4 (12.9)…VIPOC4 May 2022